MeSH term
Frequency | Condition_Probility | Chromosome Mapping | 9 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Female | 33 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Humans | 77 | 0.0 |
Male | 36 | 0.0 |
Pedigree | 15 | 0.0 |
Recurrence | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 47 | 0.0 |
Animals | 32 | 0.0 |
Child | 11 | 0.0 |
*Drosophila Proteins | 16 | 1.0 |
Endothelin-3/genetics | 12 | 92.0 |
Hirschsprung Disease/complications/*genetics | 2 | 66.0 |
Infant | 14 | 0.0 |
Mice | 15 | 0.0 |
Mice, Knockout | 2 | 0.0 |
*Mutation | 21 | 0.0 |
Nerve Growth Factors/genetics | 4 | 12.0 |
Proto-Oncogene Proteins/*genetics | 10 | 1.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 12 | 3.0 |
Receptor, Endothelin B | 42 | 70.0 |
Receptors, Endothelin/genetics | 13 | 86.0 |
Alleles | 3 | 0.0 |
Chromosomes, Human, Pair 10/genetics | 2 | 2.0 |
Genetic Markers | 3 | 0.0 |
Hirschsprung Disease/*genetics | 34 | 45.0 |
Models, Genetic | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Base Sequence | 18 | 0.0 |
*DNA Methylation | 7 | 1.0 |
DNA Primers/chemistry | 3 | 0.0 |
Gene Expression | 4 | 0.0 |
Molecular Sequence Data | 20 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Receptors, Endothelin/*genetics/metabolism | 7 | 100.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Consanguinity | 3 | 0.0 |
DNA Mutational Analysis | 8 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Homozygote | 5 | 0.0 |
Mutation | 14 | 0.0 |
Phenotype | 12 | 0.0 |
Receptors, Endothelin/*genetics | 24 | 88.0 |
Syndrome | 4 | 0.0 |
Waardenburg's Syndrome/genetics | 3 | 14.0 |
Disease Models, Animal | 3 | 0.0 |
Hirschsprung Disease/*genetics/pathology | 2 | 28.0 |
Mice, Inbred Strains | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Pregnancy | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
Karyotyping | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
CHO Cells | 3 | 0.0 |
Calcium/metabolism | 4 | 0.0 |
Hamsters | 3 | 0.0 |
Protein Binding | 4 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Signal Transduction | 6 | 0.0 |
Transfection | 3 | 0.0 |
Chromosomes, Human, Pair 1/genetics | 2 | 1.0 |
Chromosomes, Human, Pair 13/genetics | 3 | 4.0 |
DNA/genetics | 3 | 0.0 |
Lod Score | 2 | 0.0 |
English Abstract | 7 | 0.0 |
CpG Islands/*genetics | 2 | 2.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Prostatic Neoplasms/*genetics/metabolism | 2 | 5.0 |
Case-Control Studies | 4 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
*Nerve Growth Factors | 4 | 2.0 |
Nerve Tissue Proteins/genetics | 3 | 1.0 |
Polymorphism, Single-Stranded Conformational | 10 | 0.0 |
Proto-Oncogene Proteins/genetics | 5 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics | 7 | 4.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Hair Color/*genetics | 2 | 7.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Aged | 4 | 0.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Isoenzymes/genetics | 2 | 0.0 |
Middle Aged | 5 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Prognosis | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Receptors, Retinoic Acid/genetics | 2 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Tumor Suppressor Proteins/genetics | 3 | 4.0 |
Adult | 4 | 0.0 |
Chromosomes, Human, Pair 10 | 2 | 1.0 |
Point Mutation | 4 | 0.0 |
COS Cells | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Endothelin-1/metabolism | 2 | 10.0 |
Endothelin-3/metabolism | 2 | 100.0 |
Ligands | 2 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Child, Preschool | 9 | 0.0 |
Infant, Newborn | 7 | 0.0 |
Variation (Genetics) | 4 | 0.0 |
Endothelin-3/*genetics | 5 | 83.0 |
Nerve Tissue Proteins/*genetics | 3 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Sequence Deletion | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Epistasis, Genetic | 2 | 3.0 |
Transcription Factors/genetics | 2 | 0.0 |
Waardenburg's Syndrome/*genetics | 2 | 5.0 |
Family Health | 2 | 0.0 |
Adolescent | 4 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
*Point Mutation | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Gene Deletion | 4 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Heterozygote | 9 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Melanocytes | 2 | 40.0 |
Rats | 4 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Horse Diseases/*genetics | 2 | 40.0 |
Exons | 4 | 0.0 |
Disease Progression | 2 | 0.0 |
*Gene Silencing | 2 | 1.0 |
Hirschsprung Disease/genetics | 3 | 18.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
Haplotypes | 2 | 0.0 |
Genotype | 4 | 0.0 |
Germ-Line Mutation | 2 | 0.0 |
Neural Crest/growth & development | 2 | 66.0 |
Hirschsprung Disease/*genetics/physiopathology | 3 | 100.0 |
Chromosomes, Human, Pair 13 | 2 | 1.0 |
Linkage Disequilibrium | 3 | 0.0 |
China | 2 | 0.0 |
Receptor, Endothelin B/*genetics | 2 | 100.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 2 | 3.0 |
High Mobility Group Proteins/*genetics | 2 | 2.0 |
